Literature DB >> 1294836

Concentration of cocaine and metabolites in plasma of humans following intravenous administration and smoking of cocaine.

D S Isenschmid1, M W Fischman, R W Foltin, Y H Caplan.   

Abstract

Plasma was obtained from 10 human subjects at various intervals after administration of two rapid doses of cocaine, either intravenously or by smoking, and multiple doses by smoking and intravenously. The plasma was analyzed for COC and its metabolites, benzoylecgonine (BE) and ecgonine methyl ester (EME). Plasma concentrations of COC were found to be dose-dependent. For patients receiving two successive doses of COC intravenously (IV) or by smoking (SM), the average half-life of COC was found to be between 38 and 39 minutes, regardless of the dose or route of administration. Considerable interindividual variation was observed. Multiple doses of both SM and IV COC were administered to three patients in a manner consistent with COC abuse. The maximum COC concentration observed was 1.2 mg/L following a total administration of 316 mg of COC over 90 min. Analysis of BE and EME confirmed that BE is the principle metabolite of COC in blood. All COC was accounted for by BE. EME, when present, did not exceed 5% of the BE concentration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1294836     DOI: 10.1093/jat/16.5.311

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  8 in total

1.  Revisiting a physiologically based pharmacokinetic model for cocaine with a forensic scope.

Authors:  María Elena Bravo-Gómez; Laura Nayeli Camacho-García; Luz Alejandra Castillo-Alanís; Miguel Ángel Mendoza-Meléndez; Alejandra Quijano-Mateos
Journal:  Toxicol Res (Camb)       Date:  2019-03-13       Impact factor: 3.524

2.  Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized, freely moving male rats.

Authors:  R M Booze; A F Lehner; D R Wallace; M A Welch; C F Mactutus
Journal:  Neurotoxicol Teratol       Date:  1997 Jan-Feb       Impact factor: 3.763

3.  Covalent modification of proteins by cocaine.

Authors:  Shi-Xian Deng; Narine Bharat; Marian C Fischman; Donald W Landry
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

4.  Behavioral responses during the initial exposures to a low dose of cocaine in late preweanling and adult rats.

Authors:  Kiersten S Smith; Joan I Morrell
Journal:  Neurotoxicol Teratol       Date:  2008-01-19       Impact factor: 3.763

5.  The effect of ethanol on oral cocaine pharmacokinetics reveals an unrecognized class of ethanol-mediated drug interactions.

Authors:  Robert B Parker; S Casey Laizure
Journal:  Drug Metab Dispos       Date:  2009-11-17       Impact factor: 3.922

6.  Simultaneous liquid chromatography-mass spectrometry quantification of urinary opiates, cocaine, and metabolites in opiate-dependent pregnant women in methadone-maintenance treatment.

Authors:  Diaa M Shakleya; Riet Dams; Robin E Choo; Hendree Jones; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2010 Jan-Feb       Impact factor: 3.367

7.  Prenatal IV Cocaine: Alterations in Auditory Information Processing.

Authors:  Charles F Mactutus; Steven B Harrod; Lauren L Hord; Landhing M Moran; Rosemarie M Booze
Journal:  Front Psychiatry       Date:  2011-06-28       Impact factor: 4.157

8.  Effects of substance use on monetary delay discounting among people who use stimulants with and without HIV: An ecological momentary assessment study.

Authors:  Yunan Xu; Sheri L Towe; Shakiera T Causey; Paul A Dennis; Christina S Meade
Journal:  Exp Clin Psychopharmacol       Date:  2020-08-06       Impact factor: 3.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.